Trials / Completed
CompletedNCT03899571
Prophylactic Treatment With Oseltamivir
Duration of Prophylactic Treatment With Oseltamivir: A Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 222 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of 5-day versus 10-day oseltamivir prophylactic treatment in patients who had been exposed to influenza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oseltamivir Oral Capsule for 5 days post-exposure | Patients will receive oseltamivir for 5 days after last influenza exposure. |
| DRUG | Oseltamivir Oral Capsule for 10 days post-exposure | Patients will receive oseltamivir for 10 days after last influenza exposure. |
Timeline
- Start date
- 2019-01-22
- Primary completion
- 2020-03-31
- Completion
- 2020-03-31
- First posted
- 2019-04-02
- Last updated
- 2020-11-03
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT03899571. Inclusion in this directory is not an endorsement.